PURE Biosciences Inc (OTCQB:PURE)

Data as of Oct 22
 -0.05 / -4.39%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

PURE Bioscience, Inc. is engaged in the discovery, development and commercialization of bioscience products that provide solutions to global health challenges. Its technology platform is based on stabilized ionic silver and its products include PURE, Axen 30, Silverion and Axenohl, which contain silver dihydrogen citrate. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.

Contact Information

PURE Bioscience, Inc.
1725 Gillespie Way
El Cajon California 92020-1098
P:(619) 596-8600
Investor Relations:



Mutual fund holders3.31%
Individual stakeholders14.49%
Other institutional0.00%

Top Executives

Henry R. LambertChief Executive Officer & Director
Peter C. WulffSecretary, Chief Operating & Financial Officer
Bridget TinsleyVice President-Market Development
Tom MyersExecutive VP-Marketing & Product Development
Cliff WechslerExecutive Vice President-Sales

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.